Mammary involution and breast cancer risk: transgenic models and clinical studies.
about
Impact of library preparation on downstream analysis and interpretation of RNA-Seq data: comparison between Illumina PolyA and NuGEN Ovation protocol.The Susan G. Komen for the Cure Tissue Bank at the IU Simon Cancer Center: a unique resource for defining the "molecular histology" of the breast.MMTV-cre;Ccn6 knockout mice develop tumors recapitulating human metaplastic breast carcinomas.Analysis of inhibitor of apoptosis protein family expression during mammary gland development.ROS-induced epithelial-mesenchymal transition in mammary epithelial cells is mediated by NF-kB-dependent activation of Snail.The contribution of dynamic stromal remodeling during mammary development to breast carcinogenesisRemodeling of endogenous mammary epithelium by breast cancer stem cellsThe BCL9-2 proto-oncogene governs estrogen receptor alpha expression in breast tumorigenesisTerminal duct lobular unit involution of the normal breast: implications for breast cancer etiologyHormonal induction and roles of Disabled-2 in lactation and involution.Loss of PPARγ expression in mammary secretory epithelial cells creates a pro-breast tumorigenic environment.Cathepsin D: Regulation in mammary gland remodeling, misregulation in breast cancerMammary gland reprogramming: metalloproteinases couple form with functionTemporal trends in the inflammatory cytokine profile of human breastmilk.ZnT2 is a critical mediator of lysosomal-mediated cell death during early mammary gland involution.Endogenous sex hormones and breast density in young women.DNA damage and breast cancerMammary gland specific expression of Brk/PTK6 promotes delayed involution and tumor formation associated with activation of p38 MAPK.A new role of SNAI2 in postlactational involution of the mammary gland links it to luminal breast cancer development.Singleminded-2s (Sim2s) promotes delayed involution of the mouse mammary gland through suppression of Stat3 and NFκBNucling, a novel apoptosis-associated protein, controls mammary gland involution by regulating NF-κB and STAT3.Insulin-like growth factor-1, insulin-like growth factor binding protein-3 and lobule type in the Nurses' Health Study IIBenign breast disease and the risk of subsequent breast cancer in African American women.Mouse mammary gland is refractory to the effects of ethanol after natural lactation.Natural history of age-related lobular involution and impact on breast cancer risk.Comparative study and meta-analysis of meta-analysis studies for the correlation of genomic markers with early cancer detection.Obesity, metabolism and the microenvironment: Links to cancerLOXL2-mediated matrix remodeling in metastasis and mammary gland involution.Epithelial Plasticity During Human Breast Morphogenesis and Cancer Progression.Involution of breast tissue and mammographic density.Developmental windows of breast cancer risk provide opportunities for targeted chemoprevention.The spectrum of STAT functions in mammary gland developmentHormonal regulation of the immune microenvironment in the mammary gland.Hyaluronan and RHAMM in wound repair and the "cancerization" of stromal tissues.Two Faces of Cathepsin D: Physiological Guardian Angel and Pathological Demon.miR-424(322)/503 is a breast cancer tumor suppressor whose loss promotes resistance to chemotherapyReproductive factors related to childbearing and mammographic breast density.Standardized measures of lobular involution and subsequent breast cancer risk among women with benign breast disease: a nested case-control study.Association between local inflammation and breast tissue age-related lobular involution among premenopausal and postmenopausal breast cancer patients.MAP3K1: Genomic Alterations in Cancer and Function in Promoting Cell Survival or Apoptosis.
P2860
Q30663457-74583BD5-30EF-4A83-B3ED-BC2822608E56Q33454487-6EAC1EE7-9EDB-41D7-9900-5487E280DFDDQ33585917-90E9EF9D-ABAF-451D-9247-184F81E3D63AQ33618500-C483A613-BEBE-457E-BEB4-7CB08CDE05C8Q33757116-16F19D4D-C61A-41E9-B43E-E6C4D9442D80Q34048057-C6A9A28B-6296-405E-A8E1-30C91BA30CD2Q34154365-20DD659E-4BD1-4879-B42F-31A592441D21Q34334394-B0187325-4D53-4AFD-A555-54334331E4AEQ34354399-D581ACCA-487D-4830-971A-E91EDB19ADC2Q34434655-C3450D14-6C74-4534-9194-239D31E5DEB8Q34522002-E5AC34D3-C448-47B8-9C37-5B85F08AA443Q34582202-CF93F3F8-560A-4619-A192-3C21F0EC55D5Q34706838-7ACDBDA5-96AD-4049-B1D0-2AB547E997C8Q34707840-3CF94332-C856-49A5-99C1-471742A1D411Q35011972-A74773FF-1DEA-4F8D-AEFA-14AF90115CF6Q35071023-1A63C56F-82B7-42F7-BAB6-3C9D52605028Q35201664-734CF7A1-77E7-4B2E-9D15-4C14191B4370Q35683544-5C484D96-28E3-4C47-92F1-195E42660425Q36029588-57D98EB1-4F0E-4ED6-9086-6F28D9ED46D8Q36067460-564858E8-3F26-4FB1-91DC-234D9BEFAF2DQ36115911-76A8E367-0BB2-40C5-9EAC-EB5A4AA026EAQ36245524-1F0C76D1-298E-46D0-A00A-AE8F006111A2Q36456742-94B2972F-01FE-47CE-984C-8BCDB486FDA7Q36595433-52CE3B4C-8DED-4F3F-9315-299738ACDBA3Q36610181-2FAE9406-AE91-4307-99D9-CE08C93FC04BQ36940496-AB261325-3B2E-4D9C-A85B-28D37EB094A6Q37276139-D2C8F983-B156-4419-A46A-B321DD3BCB1AQ37346579-CB5FB20B-9CFB-45BD-952D-515661F20173Q37507345-8AE880C8-C4A8-4101-989D-489110164CA4Q37508938-DC7EA6C4-3A21-418A-A61B-8BD4CCC5B2CAQ37692972-1D324089-06B3-468D-A923-3E32DDF1725DQ38140889-3D5B10C0-FA51-420F-AFD9-4AE40693F4A7Q38226179-4A1B5A18-2824-4BC3-9493-0810AB35519FQ38243335-2FF9A989-B67F-4FCC-8AEF-CEBC75AFF343Q38348743-72C6EC83-8C92-4D3C-9C15-BC76C996E536Q38707925-08A75CA4-E998-4CD5-9C8D-4AB6DE047901Q39649230-D9A04050-44E1-429C-B2DF-F215A7DA26A5Q40637174-9231BDEA-32D4-4526-BF3A-D0AB3C9125D2Q41533125-0523A453-4B3F-4757-9FF1-3BEA1E376444Q41844910-C89EF6E0-2822-4C1E-BDFB-6A716779E5AC
P2860
Mammary involution and breast cancer risk: transgenic models and clinical studies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mammary involution and breast cancer risk: transgenic models and clinical studies.
@en
Mammary involution and breast cancer risk: transgenic models and clinical studies.
@nl
type
label
Mammary involution and breast cancer risk: transgenic models and clinical studies.
@en
Mammary involution and breast cancer risk: transgenic models and clinical studies.
@nl
prefLabel
Mammary involution and breast cancer risk: transgenic models and clinical studies.
@en
Mammary involution and breast cancer risk: transgenic models and clinical studies.
@nl
P2860
P921
P1476
Mammary involution and breast cancer risk: transgenic models and clinical studies.
@en
P2093
Derek C Radisky
Lynn C Hartmann
P2860
P2888
P304
P356
10.1007/S10911-009-9123-Y
P577
2009-04-30T00:00:00Z
2009-06-01T00:00:00Z